Literature DB >> 7068117

Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system.

J Aldershvile, O Dietrichson, P Skinhøj, P Kryger, L R Mathiesen, P Christoffersen, J O Nielsen.   

Abstract

In order to evaluate the prognostic implications of the hepatitis B e system in patients with chronic persistent hepatitis (CPH), 53 consecutive patients were studied. Fourteen of 16 patients with HBsAg and HBeAg were followed from 12 to 120 months (mean, 38 months). Eleven of the 14 patients were persistently HBeAg positive and five of these developed chronic active hepatitis (CAH) or cirrhosis. A further nine patients were HBsAg positive but HBeAg negative at time of CPH diagnosis (mean follow-up, 47 months). One of these nine patients developed CAH during follow-up. The remaining 28 patients were all HBsAg negative, and only 2 or the 28 patients progressed to CAH or cirrhosis during the time of follow-up (mean, 43 months). It is concluded that the persistence of HBeAg in patients with CPH indicates a serious prognosis with a frequent transition to CAH or cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068117     DOI: 10.1002/hep.1840020209

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

Review 2.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

3.  Natural history and prognostic factors for chronic hepatitis type B.

Authors:  G Fattovich; L Brollo; G Giustina; F Noventa; P Pontisso; A Alberti; G Realdi; A Ruol
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

4.  Immunopathologic aspects of woodchuck hepatitis.

Authors:  D Frommel; D Crevat; L Vitvitsky; C Pichoud; O Hantz; M Chevalier; J A Grimaud; J Lindberg; C G Trépo
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

5.  Chronic non-A, non-B hepatitis in drug addicts--a follow-up study.

Authors:  R Wejstål; J Lindberg; P Lundin; B G Hansson; G Norkrans
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 6.  The use of interferon-alpha in virus infections.

Authors:  N B Finter; S Chapman; P Dowd; J M Johnston; V Manna; N Sarantis; N Sheron; G Scott; S Phua; P B Tatum
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.